Senior Vice President, Finance and Chief Accounting Officer · ALX ONCOLOGY HOLDINGS INC (ALXO)

Shelly Pinto

A named executive officer of ALX ONCOLOGY in every fiscal year CompBrief holds from FY2021 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,505,161

Salary $378,776Stock awards $396,000Bonus $25,000

FY2021: $7,116,319

5th of 6 named executive officers at ALX Oncology by FY2024 total.

6 named officers on file for ALX ONCOLOGY, FY2024

Shelly Pinto’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • ALXO’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how ALX ONCOLOGY’s whole pay program stands against its peers

  • ALX ONCOLOGY’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ALXO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 21, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Shelly Pinto’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Shelly Pinto compensation by year

ALX ONCOLOGY Summary Compensation Table · all 2 fiscal years held
In US dollars, as ALX ONCOLOGY reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2024
Salary$226,667$378,776
Bonus$75,000$25,000
Stock awards$0$396,000
Option awards$6,724,110$582,965
Non-equity incentive$90,542$122,420
Pension and deferred compensation$0$0
All other$0$0
Total$7,116,319$1,505,161

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ALX ONCOLOGY HOLDINGS INC DEF 14A filed April 21, 2025, accession 0000950170-25-056291, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ALX ONCOLOGY HOLDINGS INC filed document, accession 0000950170-25-056291. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2025.

$7.1M
$1.5M
FY21
FY24
SalaryBonusNon-equity incentiveStock awardsOption awards

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU18,750$31,313—
RSU16,250$27,138—
PSU13,125$21,919—
RSU10,000$16,700—
RSU4,125$6,889—
Option3,646—$58.56
Option13,021—$62.83
Option150,000—$1.66
Option27,709—$15.84
Option14,250—$11.47
Option23,250—$5.86

Per the Outstanding Equity Awards at Fiscal Year-End table in ALX ONCOLOGY HOLDINGS INC's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

10 Form 4 lines since the FY2024 proxy (filed April 21, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-08-17Sale—573$1.9387,828
2026-07-01Sale—1,404$2.0488,401
2026-03-19Sale—903$2.1786,805
2026-02-18Sale—565$2.2787,708
2026-01-26Grant or award derivative—192,000$0.00192,000
2026-01-06Sale—3,925$1.1188,273
2025-10-14Grant or award derivative—140,000$0.00140,000
2025-08-15Sale—611$0.6489,198

The 8 most recent of 10 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

ALX ONCOLOGY’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Jason LettmannChief Executive Officer$6,640,830
Sophia RandolphFormer Chief Medical Officer$3,530,138
Jaume PonsFormer President and Chief Scientific Officer$3,017,955
Peter GarciaFormer Chief Financial Officer$2,697,079
Shelly Pinto · this pageSenior Vice President, Finance and Chief Accounting Officer$1,505,161
Shelly WongSenior Vice President, Finance and Chief Accounting Officer$1,505,161

The full ALX ONCOLOGY compensation record

free company brief

This page is one person within ALX ONCOLOGY's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ALX ONCOLOGY proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ALX ONCOLOGY's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Shelly Pinto's compensation dossier · One-time report. No refunds.